| Translational medicine 2.0: from clinical diagnosis-based to molecular-targeted therapies in the era of globalization. | |
| | |
MedLine Citation:
|
PMID: 20485321 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Translational medicine encompasses the itinerary from the conception of an idea to its implementation in the diagnosis, prognosis, and treatment of human diseases. It cannot be identified as a stand-alone field; rather, it comprises a fragmented patchwork of activities, competencies, and knowledge distributed along diverse and often disparate disciplines. In standard practice, the success of a translational project is often less dependent on the validity of the original idea than on the outcome of the combination of several stochastic events. |
| | |
Authors:
|
S Albani; J Colomb; B Prakken |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical pharmacology and therapeutics Volume: 87 ISSN: 1532-6535 ISO Abbreviation: Clin. Pharmacol. Ther. Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-05-20 Completed Date: 2010-06-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372741 Medline TA: Clin Pharmacol Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 642-5 Citation Subset: AIM; IM |
Affiliation:
|
Eureka Institute for Translational Research, Siracusa, Italy. salbani@burnham.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Drug Delivery Systems* Drug Design Humans Interdisciplinary Communication Internationality Internet* Prognosis Stochastic Processes Translational Research / methods* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dosing Tacrolimus Based on CYP3A5 Genotype: Will It Improve Clinical Outcome?
Next Document: Permitting Product Liability Litigation for FDA-Approved Drugs and Devices Promotes Patient Safety.